136
Views
7
CrossRef citations to date
0
Altmetric
Review

Octreotide long-acting repeatable in the treatment of neuroendocrine tumors: patient selection and perspectives

, , &
Pages 115-122 | Published online: 06 Dec 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mingliang Fan, Yue Huang, Xinlin Zhu, Jiayu Zheng & Mingwei Du. (2023) Octreotide and Octreotide-derived delivery systems. Journal of Drug Targeting 31:6, pages 569-584.
Read now
Panagiota Papanagnou, Georgios E Papadopoulos, Theodora Stivarou & Anastasios Pappas. (2019) Toward fully exploiting the therapeutic potential of marketed pharmaceuticals: the use of octreotide and chloroquine in oncology. OncoTargets and Therapy 12, pages 319-339.
Read now

Articles from other publishers (5)

Sidra Altaf, Faiza Saleem, Azam Ali Sher & Ashiq Ali. (2022) Potential Therapeutic Strategies to Combat HCC. Current Molecular Pharmacology 15:7, pages 929-942.
Crossref
Gabriel Benyomo Mpilla, Philip Agop Philip, Bassel El-Rayes & Asfar Sohail Azmi. (2020) Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations. World Journal of Gastroenterology 26:28, pages 4036-4054.
Crossref
Emmanuel Ampofo, Lisa Nalbach, Michael D. Menger & Matthias W. Laschke. (2020) Regulatory Mechanisms of Somatostatin Expression. International Journal of Molecular Sciences 21:11, pages 4170.
Crossref
Hiroshi Nomoto, Hiraku Kameda, Akinobu Nakamura, Kazuhisa Tsuchida, So Nagai, Tatsuya Atsumi & Hideaki Miyoshi. (2019) Breakdown of Autonomously Functioning Thyroid Nodule Accompanied by Acromegaly After Octreotide Treatment. Frontiers in Endocrinology 10.
Crossref
Zainab Azam Farooqui & Aman Chauhan. (2019) Neuroendocrine Tumors in Pediatrics. Global Pediatric Health 6, pages 2333794X1986271.
Crossref